Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test for Detection of Antibody in Human, Canine, Cat, and Hamster SeraJournal of clinical microbiology, 2021-01, Vol.59 (2) [Peer Reviewed Journal]Copyright © 2021 American Society for Microbiology. ;Copyright © 2021 American Society for Microbiology. 2021 American Society for Microbiology ;ISSN: 0095-1137 ;EISSN: 1098-660X ;DOI: 10.1128/JCM.02504-20 ;PMID: 33139421Full text available |
|
2 |
Material Type: Article
|
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization AssaysViruses, 2020-05, Vol.12 (5), p.513 [Peer Reviewed Journal]COPYRIGHT 2020 MDPI AG ;Attribution ;2020 by the authors. 2020 ;ISSN: 1999-4915 ;EISSN: 1999-4915 ;DOI: 10.3390/v12050513 ;PMID: 32384820Full text available |
|
3 |
Material Type: Article
|
Development of a Rapid Focus Reduction Neutralization Test Assay for Measuring SARS‐CoV‐2 Neutralizing AntibodiesCurrent Protocols in Immunology, 2020-12, Vol.131 (1)2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com ;DOI: 10.1002/cpim.116Digital Resources/Online E-Resources |
|
4 |
Material Type: Article
|
Antibody-mediated neutralization of SARS-CoV-2Immunity, 2022-06, Vol.55 (6), p.925-944 [Peer Reviewed Journal]2022 Elsevier Inc. ;Copyright © 2022 Elsevier Inc. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2022 Elsevier Inc. 2022 Elsevier Inc. ;ISSN: 1074-7613 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2022.05.005 ;PMID: 35623355Digital Resources/Online E-Resources |
|
5 |
Material Type: Article
|
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited seraNature medicine, 2021-04, Vol.27 (4), p.620-621 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. part of Springer Nature 2021. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01270-4 ;PMID: 33558724Full text available |
|
6 |
Material Type: Article
|
Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralizationCell host & microbe, 2021-05, Vol.29 (5), p.747-751.e4 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2021.04.007 ;PMID: 33887205Full text available |
|
7 |
Material Type: Article
|
Considerable escape of SARS-CoV-2 Omicron to antibody neutralizationNature (London), 2022-02, Vol.602 (7898), p.671-675 [Peer Reviewed Journal]2021. The Author(s), under exclusive licence to Springer Nature Limited. ;Copyright Nature Publishing Group Feb 24, 2022 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-04389-z ;PMID: 35016199Full text available |
|
8 |
Material Type: Article
|
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2Nature (London), 2022-02, Vol.602 (7898), p.676-681 [Peer Reviewed Journal]2021. The Author(s), under exclusive licence to Springer Nature Limited. ;Copyright Nature Publishing Group Feb 24, 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-04388-0 ;PMID: 35016198Full text available |
|
9 |
Material Type: Article
|
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralizationNature (London), 2022-02, Vol.602 (7898), p.654-656 [Peer Reviewed Journal]2021. The Author(s). ;Copyright Nature Publishing Group Feb 24, 2022 ;The Author(s) 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-04387-1 ;PMID: 35016196Full text available |
|
10 |
Material Type: Article
|
Highly active engineered IgG3 antibodies against SARS-CoV-2Proceedings of the National Academy of Sciences - PNAS, 2021-10, Vol.118 (42), p.1 [Peer Reviewed Journal]Copyright © 2021 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences Oct 19, 2021 ;Copyright © 2021 the Author(s). Published by PNAS. 2021 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2107249118 ;PMID: 34599091Full text available |
|
11 |
Material Type: Article
|
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced seraCell, 2021-04, Vol.184 (9), p.2348-2361.e6 [Peer Reviewed Journal]2021 The Author(s) ;Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. ;2021 The Author(s) 2021 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.02.037 ;PMID: 33730597Full text available |
|
12 |
Material Type: Article
|
Robust neutralizing antibodies to SARS-CoV-2 infection persist for monthsScience, 2020-12, Vol.370 (6521) [Peer Reviewed Journal]2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abd7728Digital Resources/Online E-Resources |
|
13 |
Material Type: Article
|
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodiesCell, 2021-04, Vol.184 (9), p.2384-2393.e12 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.03.036 ;PMID: 33794143Full text available |
|
14 |
Material Type: Article
|
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodiesNature medicine, 2021-04, Vol.27 (4), p.717-726 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. part of Springer Nature 2021. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01294-w ;PMID: 33664494Full text available |
|
15 |
Material Type: Article
|
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serumCell, 2021-08, Vol.184 (16), p.4220-4236.e13 [Peer Reviewed Journal]2021 The Authors ;Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved. ;2021 The Authors 2021 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.06.020 ;PMID: 34242578Full text available |
|
16 |
Material Type: Article
|
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodiesScience, 2020-08, Vol.369 (6506) [Peer Reviewed Journal]2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abd0831Digital Resources/Online E-Resources |
|
17 |
Material Type: Article
|
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodiesNature (London), 2022-02, Vol.602 (7898), p.657-663 [Peer Reviewed Journal]2021. The Author(s). ;Copyright Nature Publishing Group Feb 24, 2022 ;The Author(s) 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-04385-3 ;PMID: 35016194Full text available |
|
18 |
Material Type: Article
|
Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization TestClinical chemistry (Baltimore, Md.), 2021-05, Vol.67 (5), p.742-752 [Peer Reviewed Journal]American Association for Clinical Chemistry 2021. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2021 ;American Association for Clinical Chemistry 2021. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;COPYRIGHT 2021 Oxford University Press ;Distributed under a Creative Commons Attribution 4.0 International License ;2021 American Association for Clinical Chemistry 2021 ;ISSN: 0009-9147 ;EISSN: 1530-8561 ;DOI: 10.1093/clinchem/hvaa336 ;PMID: 33399823Full text available |
|
19 |
Material Type: Article
|
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasmaNature (London), 2021-05, Vol.593 (7857), p.142-146 [Peer Reviewed Journal]Copyright Nature Publishing Group May 6, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03471-w ;PMID: 33780970Full text available |
|
20 |
Material Type: Article
|
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7Nature (London), 2021-05, Vol.593 (7857), p.130-135 [Peer Reviewed Journal]Copyright Nature Publishing Group May 6, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03398-2 ;PMID: 33684923Full text available |